{
    "nct_id": "NCT04211259",
    "official_title": "The Prophylactic Use of Loratadine for Granulocyte-Colony Stimulating Factor (G-CSF) Induced Bone Pain in Multiple Myeloma Patients Undergoing Stem Cell Mobilization",
    "inclusion_criteria": "* Patient must be able to provide informed consent\n* Patients with confirmed diagnosis of multiple myeloma\n* Able to swallow and retain oral medication\n* All ethnic groups are eligible\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Non-English speaking person\n* Patients undergoing haploidentical allogeneic hematopoietic stem cell transplant\n* Known allergies, hypersensitivity, or intolerance to any of the study medications, excipients, or similar compounds\n* Any medical complications or conditions that would, in the investigator's judgement, interfere with full participation in the study\n* On therapeutic dose of aspirin (doses greater than 81 mg) within 7 days prior to the start of the study",
    "miscellaneous_criteria": ""
}